J Cancer
2025; 16(7):2360-2361.
doi:10.7150/jca.113959 This issueCite
Erratum
Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum
1. Breast Cancer Center, Shanghai East Hospital, Tongji University, Shanghai 200120, PR China 2. Department of Pharmacy, Shanghai East Hospital, Tongji University, Shanghai 200120, PR China *Authors contributed equally to this work.
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer 2025; 16(7):2360-2361. doi:10.7150/jca.113959. https://www.jcancer.org/v16p2360.htm
The original version of this article contained errors in Figure 7B. Specifically, three HE-stained images were incorrectly used; two images (heart and spleen) are from the DOX group, while one image (heart) is from the CYC+DOX group. These errors have now been corrected. All other images in the figure remain unchanged, and the interpretation of the results is unaffected. The authors apologize for any inconvenience this may have caused. The correct images appear below.
Figure 7
Histopathological examination of tumors and organs isolated from nude mice after different treatments on day 14. (b). H&E staining of main organs.
Lu, Y.l., Ma, Y.b., Feng, C., Zhu, D.l., Liu, J., Chen, L., Liang, S.j., Dong, C.y. (2025). Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. Journal of Cancer, 16(7), 2360-2361. https://doi.org/10.7150/jca.113959.
ACS
Lu, Y.l.; Ma, Y.b.; Feng, C.; Zhu, D.l.; Liu, J.; Chen, L.; Liang, S.j.; Dong, C.y. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J. Cancer 2025, 16 (7), 2360-2361. DOI: 10.7150/jca.113959.
NLM
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer 2025; 16(7):2360-2361. doi:10.7150/jca.113959. https://www.jcancer.org/v16p2360.htm
CSE
Lu Yl, Ma Yb, Feng C, Zhu Dl, Liu J, Chen L, Liang Sj, Dong Cy. 2025. Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum. J Cancer. 16(7):2360-2361.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.